Stay updated on Tisotumab Vedotin in Cervical Cancer Clinical Trial

Sign up to get notified when there's something new on the Tisotumab Vedotin in Cervical Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tisotumab Vedotin in Cervical Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in a medical trial related to evaluating the efficacy and safety of tisotumab vedotin in patients with previously treated, recurrent, or metastatic cervical cancer.
    Difference
    0.1%
    Check dated 2024-06-06T14:25:28.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for participation in the study, specifying the health conditions and prior treatments required for patients with extra-pelvic metastatic or recurrent cervical cancer. Previously, no information was provided regarding participation criteria.
    Difference
    17%
    Check dated 2024-05-22T21:14:32.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:59:08.000Z thumbnail image

Stay in the know with updates to Tisotumab Vedotin in Cervical Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tisotumab Vedotin in Cervical Cancer Clinical Trial page.